Jane Street
TNYA icon

Jane Street’s Tenaya Therapeutics TNYA Stock Holding History

Jane Street’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,800
Closed -$10.2K – 13135
2026
Q1 		$10.2K Buy
14,800
+2,800
+23% +$2.07K ﹤0.01% 11302
2025
Q4 		$8.54K Buy
+12,000
New +$16.3K ﹤0.01% 10862

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street's TNYA Position: Q2 2026 in Review

Jane Street reduced its Tenaya Therapeutics (TNYA) stake by 62% in Q2 2026, selling an estimated $554K and leaving 450,435 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #8993.

Jane Street first reported a position in TNYA in Q4 2022 and has held it in 14 quarters since. The position peaked at $817K in Q1 2026. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Jane Street held 450,435 shares of Tenaya Therapeutics worth $333K as of Q2 2026.
  • Jane Street sold 729,646 Tenaya Therapeutics shares in Q2 2026, an estimated $554K.
  • Tenaya Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8993 holding.
  • Jane Street first reported a position in Tenaya Therapeutics in Q4 2022 and has held it in 14 quarters since.
  • Jane Street's Tenaya Therapeutics position peaked at $817K in Q1 2026.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.